Archives
Navigating Life with Hypertrophic Cardiomyopathy
Array Array (Feature Impact) Living with obstructive or non-obstructive hypertrophic cardiomyopathy (HCM) can affect everyday life, your plans and the people around you. For some people, every morning with the…
Exclusively Sponsored by Sinopec’s Aipao Racing Fuel, the 2026 China Taklimakan Rally Kicks Off in Urumqi
B URUMQI, China, May 18, 2026 /PRNewswire/ — With the command to start, 152 vehicles and nearly 300 competitors of 74 teams from around the world embarked on a 7,500-kilometer…
Labbit Introduces Validation Assistant as the Latest Addition to Its Change Management Lifecycle for Regulated Laboratories
B New capability automates test planning, execution, and audit-ready documentation for system updates in regulated laboratories. VANCOUVER, BC, May 18, 2026 /PRNewswire/ – Labbit, a leader in laboratory informatics, is…
Rockefeller Foundation Awarded US$350M+ to Reach 731 Million People Amid 2025’s Historic Decline in Global Aid
B 2025 Impact Report, “Big Bets, Real Results,” highlights $32 billion in total capital mobilized into solutions for millions of people in Africa, Asia, Latin America & the Caribbean, Europe,…
TDConnex wins Leading Innovator of the Year award for Electronics at India’s 2026 MSME Awards
B TDConnex was one of two recipients in the Electronics category for the prestigious national MSME award in India for 2026. CHENNAI, India, May 17, 2026 /PRNewswire/ — TDConnex, a…
The Anime Effect: How Fans Are Travelling Across Asia for Real-World Experiences
B Anime culture drives travel as fans flock to real-world anime sites and festivals 195% YoY surge in searches for anime and comic-related travel experiences across Asia SINGAPORE, May 17,…
ZTE Showcases at GSMA M360 LATAM 2026, Driving Future Business Model Restructuring — AI & Network Two-Way Integration
B ZTE provides an in-depth analysis of the industrial value of the two-way integration of AI and networks ZTE continues to consolidate its presence in Latin America, and deploy green,…
Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate
B Hu-mAtrIx™-Enabled Next-Generation ACVR2A/2B- Targeting Antibody Demonstrates Potential to Become a Best-in-Class Therapy for Obesity CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, May 17, 2026 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of…
WuXi AppTec Recognized as a Top-Performing Company on 2026 Dow Jones Best-in-Class World Index
B SHANGHAI, May 17, 2026 /PRNewswire/ — WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has been selected for the 2026 Dow Jones Best-in-Class World…
LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma
B SEOUL, South Korea, May 17, 2026 /PRNewswire/ — LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company…

